相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The Emerging Role of Glucagon-like Peptide-1 Receptor Agonists for the Management of NAFLD
Chandani Patel Chavez et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2022)
Differential association between the GLP1R gene variants and brain functional connectivity according to the severity of alcohol use
Mehdi Farokhnia et al.
SCIENTIFIC REPORTS (2022)
Role of the ghrelin system in alcohol use disorder and alcohol-associated liver disease: A narrative review
Kusum K. Kharbanda et al.
ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH (2022)
How Far beyond Diabetes Can the Benefits of Glucagon-like Peptide-1 Receptor Agonists Go? A Review of the Evidence on Their Effects on Hepatocellular Carcinoma
Konstantinos Arvanitakis et al.
CANCERS (2022)
Glucagon-Like Peptide-1 Receptor Agonists for Treatment of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis: An Updated Meta-Analysis of Randomized Controlled Trials
Alessandro Mantovani et al.
METABOLITES (2021)
Alcohol-mediated behaviours and the gut-brain axis; with focus on glucagon-like peptide-1
Elisabet Jerlhag
BRAIN RESEARCH (2020)
Anti-Lipolysis Induced by Insulin in Diverse Pathophysiologic Conditions of Adipose Tissue
Jia Zhao et al.
DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY (2020)
GLP-1 receptor agonists in the treatment of type 2 diabetes-state-of-the-art
Michael A. Nauck et al.
MOLECULAR METABOLISM (2020)
Long-Acting Glucagon-Like Peptide-1 Receptor Agonists Suppress Voluntary Alcohol Intake in Male Wistar Rats
Vincent N. Marty et al.
FRONTIERS IN NEUROSCIENCE (2020)
Epidemiology of non-alcoholic and alcoholic fatty liver diseases
Souveek Mitra et al.
TRANSLATIONAL GASTROENTEROLOGY AND HEPATOLOGY (2020)
Epidemiology of Alcohol Consumption and Societal Burden of Alcoholism and Alcoholic Liver Disease
Page D. Axley et al.
CLINICS IN LIVER DISEASE (2019)
Inflammatory pathways in alcoholic steatohepatitis
Bin Gao et al.
JOURNAL OF HEPATOLOGY (2019)
Chronic alcohol exposure alters circulating insulin and ghrelin levels: role of ghrelin in hepatic steatosis
Karuna Rasineni et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2019)
Glucagon-like peptide 1 (GLP-1)
T. D. Mueller et al.
MOLECULAR METABOLISM (2019)
Inhibition of Ghrelin Activity by Receptor Antagonist [D-Lys-3] GHRP-6 Attenuates Alcohol-Induced Hepatic Steatosis by Regulating Hepatic Lipid Metabolism
Karuna Rasineni et al.
BIOMOLECULES (2019)
Serum Metabolomic Profiling Identifies Key Metabolic Signatures Associated With Pathogenesis of Alcoholic Liver Disease in Humans
Zhihong Yang et al.
HEPATOLOGY COMMUNICATIONS (2019)
The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
Naga Chalasani et al.
HEPATOLOGY (2018)
Alcohol, adipose tissue and liver disease: mechanistic links and clinical considerations
Richard Parker et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2018)
Exendin-4 reduces food intake via the PI3K/AKT signaling pathway in the hypothalamus
Yan Yang et al.
SCIENTIFIC REPORTS (2017)
Exendin-4 protects mice from D-galactose-induced hepatic and pancreatic dysfunction
Akram Ahangarpour et al.
PATHOBIOLOGY OF AGING AND AGE-RELATED DISEASES (2017)
Ethanol-Induced Steatosis Involves Impairment of Lipophagy, Associated With Reduced Dynamin2 Activity
Karuna Rasineni et al.
HEPATOLOGY COMMUNICATIONS (2017)
Alcohol, Adipose Tissue and Lipid Dysregulation
Jennifer L. Steiner et al.
BIOMOLECULES (2017)
Alcoholic vs non-alcoholic fatty liver in rats: distinct differences in endocytosis and vesicle trafficking despite similar pathology
Karuna Rasineni et al.
BMC GASTROENTEROLOGY (2016)
Glucagon-like peptide 1 improves insulin resistance in vitro through anti-inflammation of macrophages
C. Guo et al.
BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH (2016)
Alcoholic Liver Disease: The Gut Microbiome and Liver Cross Talk
Phillipp Hartmann et al.
ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH (2015)
Ethanol-induced hepatic steatosis is modulated by glycogen level in the liver
Jin Gu et al.
JOURNAL OF LIPID RESEARCH (2015)
The glucagon-like peptide-1 receptor as a potential treatment target in alcohol use disorder: evidence from human genetic association studies and a mouse model of alcohol dependence
P. Suchankova et al.
TRANSLATIONAL PSYCHIATRY (2015)
Rab GTPases Associate with Isolated Lipid Droplets (LDs) and Show Altered Content After Ethanol Administration: Potential Role in Alcohol-Impaired LD Metabolism
Karuna Rasineni et al.
ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH (2014)
GLP-1 Agonism Stimulates Brown Adipose Tissue Thermogenesis and Browning Through Hypothalamic AMPK
Daniel Beiroa et al.
DIABETES (2014)
The GLP-1 Analogue Exenatide Improves Hepatic and Muscle Insulin Sensitivity in Diabetic Rats: Tracer Studies in the Basal State and during Hyperinsulinemic-Euglycemic Clamp
Hui Wu et al.
JOURNAL OF DIABETES RESEARCH (2014)
Akt/PKB activation and insulin signaling: a novel insulin signaling pathway in the treatment of type 2 diabetes
Richard W. A. Mackenzie et al.
DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY (2014)
GLP-1 receptor activated insulin secretion from pancreatic ss-cells: mechanism and glucose dependence
A. R. Meloni et al.
DIABETES OBESITY & METABOLISM (2013)
Chronic Alcohol Exposure Stimulates Adipose Tissue Lipolysis in Mice
Wei Zhong et al.
AMERICAN JOURNAL OF PATHOLOGY (2012)
Regulation of Adipocyte Formation by GLP-1/GLP-1R Signaling
Tenagne Delessa Challa et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Exendin-4 Improves Steatohepatitis by Increasing Sirt1 Expression in High-Fat Diet-Induced Obese C57BL/6J Mice
Jinmi Lee et al.
PLOS ONE (2012)
Cyanamide Potentiates the Ethanol-Induced Impairment of Receptor-Mediated Endocytosis in a Recombinant Hepatic Cell Line Expressing Alcohol Dehydrogenase Activity
Dahn L. Clemens et al.
INTERNATIONAL JOURNAL OF HEPATOLOGY (2012)
Approach to the Hospitalized Patient with Severe Insulin Resistance
Jennifer Larsen et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2011)
Exendin-4, a GLP-1 receptor agonist, directly induces adiponectin expression through protein kinase A pathway and prevents inflammatory adipokine expression
Le Thi Kim Chung et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2009)
Prevention of insulin resistance by ingesting aqueous extract of Ocimum sanctum to fructose-fed rats
S. S. Reddy et al.
HORMONE AND METABOLIC RESEARCH (2008)
Chronic ethanol-induced insulin resistance is associated with macrophage infiltration into adipose tissue and altered expression of adipocytokines
Li Kang et al.
ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH (2007)
GLP-1 amplifies insulin signaling by up-regulation of IRβ, IRS-1 and Glut4 in 3T3-L1 adipocytes
Hong Gao et al.
ENDOCRINE (2007)
Exendin-4 potently decreases ghrelin levels in fasting rats
Diego Perez-Tilve et al.
DIABETES (2007)
Exendin-4, a glucagon-like protein-1 (GLP-1) receptor agonist, reverses hepatic steatosis in ob/ob mice
XK Ding et al.
HEPATOLOGY (2006)
PPARγ-mediated insulin sensitization:: the importance of fat versus muscle
U Kintscher et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2005)
Glucose sensitivity and metabolism-secretion coupling studied during two-year continuous culture in INS-1E insulinoma cells
A Merglen et al.
ENDOCRINOLOGY (2004)
An insulin-degrading enzyme inhibitor decreases amylin degradation, increases amylin-induced cytotoxicity, and increases amyloid formation in insulinoma cell cultures
RG Bennett et al.
DIABETES (2003)
Insulin signalling and the regulation of glucose and lipid metabolism
AR Saltiel et al.
NATURE (2001)
分享论文
